Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 46

Sort by

Sort Order Select

Journal Articles

Quality of Life in Childhood Immune Thrombocytopenia: Revision of the Kids' ITP Tools (KIT)

Vinita Dhir, Caseng Zhang, Nick Barrowman, Ewa Sucha, Rachael F. Grace, John D. Grainger, Nancy L Young, Robert J. Klaassen

Blood (2023) 142 (Supplement 1): 1215.

https://doi.org/10.1182/blood-2023-182449

Published: 2023

Journal Articles

Cellular and Molecular Analysis of Hematopoietic Stem and Progenitor Cells in Shwachman-Diamond Syndrome

Apichat Photia, Mariana Benicio, Efe Sahinoglu, Hongbing Li, Richard Neil Armstrong, Houtan Moshiri, Robert J. Klaassen, Yves D Pastore, John E. Dick, Yigal Dror

Blood (2023) 142 (Supplement 1): 1364.

https://doi.org/10.1182/blood-2023-190722

Published: 2023

Journal Articles

A Phase 3 Study of Eltrombopag Vs. Standard First-Line Management for Newly Diagnosed Immune Thrombocytopenia in Children: Trial in Progress Update

Blood (2023) 142 (Supplement 1): 1223.

https://doi.org/10.1182/blood-2023-172819

Published: 2023

Journal Articles

Childhood Autoimmune Hemolytic Anemia: A Scoping Review

Caseng Zhang, Danielle Charland, Katie O'Hearn, MacGregor Steele, Robert J. Klaassen, Matthew Speckert

Blood (2023) 142 (Supplement 1): 5206.

https://doi.org/10.1182/blood-2023-184916

Published: 2023

Journal Articles

Predictors of Disease Progression and Survival in Patients with Myelodysplastic Syndrome Secondary to Inherited Bone Marrow Failure Syndromes

Blood (2022) 140 (Supplement 1): 11461–11462.

https://doi.org/10.1182/blood-2022-169965

Published: 2022

Journal Articles

Face Validity of the Kid's ITP Tools (KIT) in the Era of Thrombopoietin Receptor Agonists (TPO-RAs)

Catherine McGuire, Joel Livingston, Nancy Young, Vinita Dhir, Victor Blanchette, Melanie Kirby -Allen, Robert J Klaassen

Blood (2022) 140 (Supplement 1): 13152–13153.

https://doi.org/10.1182/blood-2022-169744

Published: 2022

Journal Articles

Evaluating the Impact of Thrombopoietin Receptor Agonists Medications on Patient Outcomes and Quality of Life in Pediatric Immune Thrombocytopenia

Joel Livingston, Melanie Jackson, Ziyad Alrajihi, Catherine McGuire, Robert J Klaassen, Melanie Kirby -Allen

Blood (2021) 138 (Supplement 1): 4072.

https://doi.org/10.1182/blood-2021-146031

Published: 2021

Journal Articles

Pharmacist Integration into the Hemophilia Treatment Centre: A Canadian Pilot Project to Optimize Treatment and Improve Cost-Savings Using Pharmacokinetic Assessments of Hemophilia Patients

Nisha S Varughese, Alex Wong, Robert J Klaassen, Elaine W. Leung, Kathryn Elizabeth Webert, Sylvain Grenier, Sarah Jennings, Utsav Patel, Caitlin Jones, Simmi Sidhu, Regis Vaillancourt

Blood (2021) 138 (Supplement 1): 832.

https://doi.org/10.1182/blood-2021-147813

Published: 2021

Journal Articles

Genotypic and Phenotypic Spectrum of Dyskeratosis Congenita: Results from the Canadian Inherited Marrow Failure Registry

Blood (2020) 136 (Supplement 1): 8–9.

https://doi.org/10.1182/blood-2020-140793

Published: 2020

Journal Articles

The Impact of Identifying the Syndromic and Genetic Diagnoses on Hematopoietic Stem Cell Transplantation Outcome in Patients with Inherited Bone Marrow Failure Syndromes

Blood (2019) 134 (Supplement_1): 5015.

https://doi.org/10.1182/blood-2019-121743

Published: 2019

Journal Articles

Cellular and Molecular Architecture of Hematopoietic Stem Cells and Progenitors in Genetic Models of Bone Marrow Failure

Stephanie C. Heidemann, MD, Brian Bursic, Sasan Zandi, MD PhD, Hongbing Li, PhD, Robert J Klaassen, MD FRCPC, Sharon Abish, MD, Meera Rayar, Vicky R. Breakey, BSc,MDFRCPC, Houtan Moshiri, PhD, Santhosh Dhanraj, PhD, Richard de Borja, PhD, Adam Shlien, PhD, John E. Dick, PhD, Yigal Dror, MDFRCPC, Sagi Abelson, PhD

Blood (2019) 134 (Supplement_1): 1223.

https://doi.org/10.1182/blood-2019-130534

Published: 2019

Journal Articles

Predictors of Disease Progression and Survival in Patients with Myelodysplastic Syndrome Secondary to Inherited Bone Marrow Failure Syndromes

Blood (2019) 134 (Supplement_1): 2507.

https://doi.org/10.1182/blood-2019-130129

Published: 2019

Journal Articles

A Phase 3 Study of Eltrombopag Vs. Standard First-Line Management for Newly Diagnosed Immune Thrombocytopenia in Children

Kristin A. Shimano, MD, Rachael F. Grace, MD, Carolyn M. Bennett, MDMSc, Robert J Klaassen, MD FRCPC, Cindy Neunert, MD, Ellis J. Neufeld, MD, Clement Ma, PhD, Wendy B. London, PhD, Jenny M. Despotovic, DO, MS

Blood (2019) 134 (Supplement_1): 2369.

https://doi.org/10.1182/blood-2019-125487

Published: 2019

Journal Articles

Patient-Reported Outcome Measures (PROMs) in Pediatric Non-Malignant Hematology: A Systematic Review

Robert J Klaassen, MD FRCPC, Julia Y. Kinahan, MDcal Student, Johann M. I. Graham, MDcal Student, Yamilée V. Hébert, MDcal Student, Katie O'Hearn, MSc Human Kinetics

Blood (2019) 134 (Supplement_1): 2180.

https://doi.org/10.1182/blood-2019-127248

Published: 2019

Journal Articles

The Effect of "Pathway" to Diagnosis for Childhood ITP on Caregiver Quality of Life at Time of Diagnosis

Michelle Neier, MD, Michele P. Lambert, MD, Rachael F. Grace, MD, Kerry Hege, MD, Stephanie Chiu, MPH, Julianne Thompson, Robert J Klaassen, MD FRCPC

Blood (2019) 134 (Supplement_1): 2174.

https://doi.org/10.1182/blood-2019-125686

Published: 2019

Journal Articles

Development of Patient-Reported Outcome Measures (Symptoms and Impacts) in Adults with Pyruvate Kinase Deficiency

Sam Salek, PhDRPh FFPM MCMS MRPSGB FESCP, Audra N. Boscoe, PhD, Chris Evans, PhD, Shayna Egan, MPH, Ted Wells, Sarah Piantedosi, Jennifer Cohen, Robert J Klaassen, MD FRCPC, Rachael F. Grace, MD, Mike Storm, MSc

Blood (2019) 134 (Supplement_1): 3447.

https://doi.org/10.1182/blood-2019-128524

Published: 2019

Journal Articles

Observational Study of Real-World Factor Utilization and Health Outcomes in Patients with Hemophilia in Canada

Haowei Linda Sun, MD FRCPC, Ming Yang, PhD, Man-Chiu Poon, MD, Adrienne Lee, MD, Katherine Sue Robinson, MD, Michelle Sholzberg, MDM, MSc, FRCPC, John K. Wu, MBBS, FRCPC, MS, Alfonso Iorio, MD PhD, Victor S. Blanchette, FRCP, Robert J Klaassen, MD FRCPC, Shannon Jackson, MD FRCPC

Blood (2018) 132 (Supplement 1): 4813.

https://doi.org/10.1182/blood-2018-99-113858

Published: 2018

Journal Articles

Increasing Incidence and Prevalence of Pathologic Hemoglobinopathies Among Children in Ontario, Canada from 1991-2013

Ewurabena Simpson, MD FRCPC, MPH, Robert J Klaassen, MD FRCPC, Pranesh Chakraborty, MD FRCPC, FCCMG, Beth Potter, PhD, Melanie Ann Kirby-Allen, MBBS, Isaac Odame, Suzan Williams, MD, Uma Athale, MD MBBS, MSc, Lawrence Jardine, MD BA, FRCPC, Paul J. Gibson, MD, Mariana Silva, MD FRCPC, Manuela Merelles-Pulcini, Brooke Bowerman, BSc, William Petrcich, MSc, Eric I Benchimol, MD PhD FRCPC

Blood (2018) 132 (Supplement 1): 4698.

https://doi.org/10.1182/blood-2018-99-110468

Published: 2018

Journal Articles

Predictors of Hydroxyurea Use in Children with Sickle Cell Disease

Chisom Ifeoma Okwor, BSc, Robert J Klaassen, MD FRCPC, Mary-Ann Harrison, MSc, Ken Tang, PhD, Isabelle Laforest, MSc, ACSM, Brooke Bowerman, BSc, Ewurabena Simpson, MD FRCPC, MPH

Blood (2018) 132 (Supplement 1): 4934.

https://doi.org/10.1182/blood-2018-99-111377

Published: 2018

Journal Articles

Normalizing hepcidin predicts TMPRSS6 mutation status in patients with chronic iron deficiency

Matthew M. Heeney, Dongjing Guo, Luigia De Falco, Dean R. Campagna, Gordana Olbina, Paige P.-C. Kao, Klaus Schmitz-Abe, Fedik Rahimov, Patrick Gutschow, Keith Westerman, Vaughn Ostland, Tracy Jackson, Robert J. Klaassen, Kyriacos Markianos, Karin E. Finberg, Achille Iolascon, Mark Westerman, Wendy B. London, Mark D. Fleming

Blood (2018) 132 (4): 448–452.

https://doi.org/10.1182/blood-2017-03-773028

Published: 2018

Includes: Supplemental data

NARROW

Quality of Life in Childhood Immune Thrombocytopenia: Revision of the Kids' ITP Tools (KIT)

Cellular and Molecular Analysis of Hematopoietic Stem and Progenitor Cells in Shwachman-Diamond Syndrome

A Phase 3 Study of Eltrombopag Vs. Standard First-Line Management for Newly Diagnosed Immune Thrombocytopenia in Children: Trial in Progress Update

Childhood Autoimmune Hemolytic Anemia: A Scoping Review

Predictors of Disease Progression and Survival in Patients with Myelodysplastic Syndrome Secondary to Inherited Bone Marrow Failure Syndromes

Face Validity of the Kid's ITP Tools (KIT) in the Era of Thrombopoietin Receptor Agonists (TPO-RAs)

Evaluating the Impact of Thrombopoietin Receptor Agonists Medications on Patient Outcomes and Quality of Life in Pediatric Immune Thrombocytopenia

Pharmacist Integration into the Hemophilia Treatment Centre: A Canadian Pilot Project to Optimize Treatment and Improve Cost-Savings Using Pharmacokinetic Assessments of Hemophilia Patients

Genotypic and Phenotypic Spectrum of Dyskeratosis Congenita: Results from the Canadian Inherited Marrow Failure Registry

The Impact of Identifying the Syndromic and Genetic Diagnoses on Hematopoietic Stem Cell Transplantation Outcome in Patients with Inherited Bone Marrow Failure Syndromes

Cellular and Molecular Architecture of Hematopoietic Stem Cells and Progenitors in Genetic Models of Bone Marrow Failure

Predictors of Disease Progression and Survival in Patients with Myelodysplastic Syndrome Secondary to Inherited Bone Marrow Failure Syndromes

A Phase 3 Study of Eltrombopag Vs. Standard First-Line Management for Newly Diagnosed Immune Thrombocytopenia in Children

Patient-Reported Outcome Measures (PROMs) in Pediatric Non-Malignant Hematology: A Systematic Review

The Effect of "Pathway" to Diagnosis for Childhood ITP on Caregiver Quality of Life at Time of Diagnosis

Development of Patient-Reported Outcome Measures (Symptoms and Impacts) in Adults with Pyruvate Kinase Deficiency

Observational Study of Real-World Factor Utilization and Health Outcomes in Patients with Hemophilia in Canada

Increasing Incidence and Prevalence of Pathologic Hemoglobinopathies Among Children in Ontario, Canada from 1991-2013

Predictors of Hydroxyurea Use in Children with Sickle Cell Disease

Normalizing hepcidin predicts TMPRSS6 mutation status in patients with chronic iron deficiency

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only